Showing results (1371-1380 of 1,557) with videos related to
Sort By:
Pageof 156
Cell|December 12, 2017
YY1 Is a Structural Regulator of Enhancer-Promoter LoopsAbraham S Weintraub, Charles H Li, Alicia V Zamudio, et al.Nature|August 9, 2019
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cellsDavid N Debruyne, Ruben Dries, Satyaki Sengupta, et al.Scientific Reports|March 30, 2017
Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis modelHong Wu, Qiong Huang, Ziping Qi, et al.Chemistry & Biology|January 31, 2012
Discovery of potent and selective covalent inhibitors of JNKTinghu Zhang, Francisco Inesta-Vaquera, Mario Niepel, et al.Nature Genetics|June 3, 2020
Selective Mediator dependence of cell-type-specifying transcriptionMartin G Jaeger, Björn Schwalb, Sebastian D Mackowiak, et al.Cell Chemical Biology|September 7, 2022
Exploring the target scope of KEAP1 E3 ligase-based PROTACsGuangyan Du, Jie Jiang, Nathaniel J Henning, et al.Cell Chemical Biology|April 16, 2019
Leveraging Compound Promiscuity to Identify Targetable Cysteines within the KinomeSuman Rao, Deepak Gurbani, Guangyan Du, et al.Cancer Research|December 19, 2015
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic AnalysisJulia E Maxson, Melissa L Abel, Jinhua Wang, et al.European Journal of Medicinal Chemistry|June 20, 2017
Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitorsBeilei Wang, Yuanxin Deng, Yongfei Chen, et al.ACS Infectious Diseases|March 15, 2023
Human Polo-like Kinase Inhibitors as AntiplasmodialsMonica J Bohmer, Jinhua Wang, Eva S Istvan, et al.Pageof 156